Fusataka Koide

757 total citations
17 papers, 506 citations indexed

About

Fusataka Koide is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Fusataka Koide has authored 17 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Fusataka Koide's work include Mosquito-borne diseases and control (7 papers), Viral Infections and Vectors (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Fusataka Koide is often cited by papers focused on Mosquito-borne diseases and control (7 papers), Viral Infections and Vectors (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Fusataka Koide collaborates with scholars based in United States, Canada and Australia. Fusataka Koide's co-authors include Philip O. Livingston, Raj Kalkeri, Samuel J. Danishefsky, Scott J. Goebel, Beth A. Snyder, Jennifer R. Allen, Govind Ragupathi, Kevin Walters, Jonathan O. Rayner and Maria Spassova and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Frontiers in Microbiology.

In The Last Decade

Fusataka Koide

17 papers receiving 487 citations

Peers

Fusataka Koide
Fusataka Koide
Citations per year, relative to Fusataka Koide Fusataka Koide (= 1×) peers Jennifer Stencel-Baerenwald

Countries citing papers authored by Fusataka Koide

Since Specialization
Citations

This map shows the geographic impact of Fusataka Koide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fusataka Koide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fusataka Koide more than expected).

Fields of papers citing papers by Fusataka Koide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fusataka Koide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fusataka Koide. The network helps show where Fusataka Koide may publish in the future.

Co-authorship network of co-authors of Fusataka Koide

This figure shows the co-authorship network connecting the top 25 collaborators of Fusataka Koide. A scholar is included among the top collaborators of Fusataka Koide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fusataka Koide. Fusataka Koide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Noyce, Ryan S., José Esparza, Bruce L. Daugherty, et al.. (2023). Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge. Viruses. 15(2). 356–356. 6 indexed citations
2.
Awasthi, Mayanka, Anthony Macaluso, Fusataka Koide, et al.. (2023). Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates. Vaccines. 11(11). 1682–1682. 3 indexed citations
3.
Tyagi, Parikshit, Milan Ganguly, Sunil Gairola, et al.. (2022). Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates. Vaccine. 41(3). 836–843. 2 indexed citations
4.
Kalkeri, Raj, et al.. (2021). SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes. Microorganisms. 9(8). 1744–1744. 19 indexed citations
5.
Kalkeri, Raj, Kevin Walters, William Van Der Pol, et al.. (2021). Changes in the gut microbiome community of nonhuman primates following radiation injury. BMC Microbiology. 21(1). 93–93. 21 indexed citations
7.
Prow, Natalie A., Liang Liu, Mary K. McCarthy, et al.. (2020). The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates. npj Vaccines. 5(1). 44–44. 17 indexed citations
8.
Nouën, Cyril Le, Ursula J. Buchholz, Raj Kalkeri, et al.. (2019). 2777. Live-Attenuated Vaccine Against RSV Generates Robust Cellular and Humoral Immune Responses. Open Forum Infectious Diseases. 6(Supplement_2). S980–S980. 1 indexed citations
10.
Snyder, Beth A., Scott J. Goebel, Fusataka Koide, Roger G. Ptak, & Raj Kalkeri. (2017). Synergistic antiviral activity of Sofosbuvir and type‐I interferons (α and β) against Zika virus. Journal of Medical Virology. 90(1). 8–12. 24 indexed citations
11.
Koide, Fusataka, Scott J. Goebel, Beth A. Snyder, et al.. (2016). Development of a Zika Virus Infection Model in Cynomolgus Macaques. Frontiers in Microbiology. 7. 2028–2028. 76 indexed citations
12.
Goebel, Scott J., Beth A. Snyder, Timothy J. Sellati, et al.. (2016). A sensitive virus yield assay for evaluation of Antivirals against Zika Virus. Journal of Virological Methods. 238. 13–20. 33 indexed citations
13.
Wu, Xiaohong, Govind Ragupathi, Fusataka Koide, et al.. (2011). Impact of minimal tumor burden on antibody response to vaccination. Cancer Immunology Immunotherapy. 60(5). 621–627. 15 indexed citations
14.
Ragupathi, Govind, Fusataka Koide, Philip O. Livingston, et al.. (2006). Preparation and Evaluation of Unimolecular Pentavalent and Hexavalent Antigenic Constructs Targeting Prostate and Breast Cancer:  A Synthetic Route to Anticancer Vaccine Candidates. Journal of the American Chemical Society. 128(8). 2715–2725. 117 indexed citations
15.
Koide, Fusataka, et al.. (2005). Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity. Vaccine. 23(39). 4727–4733. 14 indexed citations
16.
Ragupathi, Govind, Fusataka Koide, Maria Spassova, et al.. (2003). A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers. Cancer Immunology Immunotherapy. 52(10). 608–616. 46 indexed citations
17.
Ragupathi, Govindaswami, Don M. Coltart, Lawrence J. Williams, et al.. (2002). On the power of chemical synthesis: Immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines. Proceedings of the National Academy of Sciences. 99(21). 13699–13704. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026